NATIONAL UNIVERSITY OF SINGAPORE

NATIONAL UNIVERSITY OF SINGAPORE has been granted 464 US utility patents between 2015 and 2025, placing NATIONAL UNIVERSITY OF SINGAPORE at rank #952 across all assignees tracked by PlainPatent. This portfolio spans 165 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.5 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, NATIONAL UNIVERSITY OF SINGAPORE is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 61.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 262 grants, compared with 202 in the 2015–2019 window — a +30% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. NATIONAL UNIVERSITY OF SINGAPORE's 16.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark NATIONAL UNIVERSITY OF SINGAPORE against peers pursuing similar technology classes.